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Abstract
Articular cartilage tissue possesses poor ability to regenerate; as the lesion 
progresses, it extends to the underlying subchondral bone and an osteochondral 
(OC) defect appears complicating the therapeutic approaches. Cartilage tissue 
engineering has become a very active research area capable of contributing to medi-
cal technology innovation. In this regard, the development of new biomaterials in 
combination with cells represents one of the best alternatives for the treatment of 
OC injuries. In the last decades, the strategies have been designed without consider-
ing the cartilage as a complex tissue with a functionally stratified three-dimensional 
structure. Today, efforts are focused on creating a starting point in the process of 
cartilage formation with the development of a multiphase implants that recapitu-
lates the cartilage as an OC unit, which improves its integration. This chapter will 
focus on a review of tissue engineering based on multiphase designs for cartilage 
and OC injuries, highlighting the importance of the biomaterial selection, and also 
the relevance of a biomimetic approach to reach a suitable microenvironment for 
the differentiation and maturation of the chondral tissue.
Keywords: osteochondral regeneration, cartilage tissue engineering,  
multiphasic designs, biofunctionalization, vascularization
1. Introduction
Clinically, an osteochondral trauma injury usually occurs in the part of the load-
bearing of the knee and ankle joint. In the particular case of the knee, as a result, 
in most animal models, osteochondral defects are created in the femoral condyles 
(Figure 1), which are subject to various types of mechanical loading, such as 
compression, shear, and hydrostatic pressure. It is commonly accepted that critical 
size osteochondral defects can induce significant degenerative changes in surround-
ing cartilage and bone, possibly due to mechanical destabilization that originates 
from the region of the defect that cannot support the load [1]. In this sense and due 
to the intrinsic properties of the chondral tissue, the repair of osteochondral defects 
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requires an approach based on tissue engineering, so that the resulting tissue can 
mimic the physiological and structural properties of two different tissues (cartilage 
and bone) by designing specific scaffold-cell constructs. Multiphase approaches 
use two or three architectures, materials, and even cell types to produce a multilayer 
construction.
The multiphasic scaffolds have been designed to influence not only the reca-
pitulation of the osteochondral architecture but also to make the integration of the 
implant with the surrounding tissue more efficient.
In the design of this type of multiphase implants, the selection of bioactive 
biopolymers and ceramics, but also the manufacturing method, and the depen-
dence or not of the cellularization of the phases in harmony with the presence of the 
signaling factors will define the therapeutic success. This chapter aims to present 
and discuss the approaches currently proposed for the use of multiphase designs in 
the treatment of chondral and osteochondral lesions.
2. The osteochondral unit
Cartilage is a type of connective tissue whose function is to protect the bones of 
the diarthrodial joints from the frictional forces associated with the load and impact 
support [2]. Articular cartilage is predominantly avascular, aneural and alymphatic, 
so the main route of nutrition is through the synovial fluid and assisted by mechanical 
compression forces [3]. It has a variable thickness according to its location in the body; 
in humans, it varies from 1 to 3 mm depending on the joint. This tissue is capable of 
being deformed to increase the total contact surface with the consequent reduction in 
tension and increase the resistance to damage caused by the applied loads. This func-
tion depends on the organization of the macromolecules in the extracellular matrix, 
particularly the arrangement and orientation of the collagen fibers [4].
The cartilage has a single type of specialized cells called chondrocytes [5], which 
are embedded and grouped in the extracellular matrix (ECM) secreted by them-
selves. The ECM is a dynamic network of self-assembled macromolecules composed 
of water, gases, metabolites, cations and collagen predominantly, noncollagenous 
glycoproteins, hyaluronate and proteoglycans are also present. The ECM is able to 
Figure 1. 
Hierarchical architecture of the osteochondral unit. The layers including superficial cartilage, middle calcified 
cartilage, and deep subchondral bone, as well as cancellous bone, are showing; also the orientation of the 
collagen fibers that give cartilage its resistance compression forces.
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regulate the behavior of cells and influences their processes of proliferation and 
maturation [6].
As part of the ECM, water has the function of allowing the deformation of 
the cartilage in response to stress; it is also important for the nourishment of the 
cartilage and the lubrication of the joints. Moreover, the capability of the articular 
cartilage to tolerate significant loads depends on the frictional resistance to water 
flow and the pressurization of water within the matrix. When the amount of water 
increases to 90%, as in osteoarthritis (OA), it causes greater permeability, which in 
turn causes a decrease in resistance and compromises elastic abilities [6].
The most abundant macromolecule in the ECM is collagen and represents 60% 
of the dry weight of the cartilage. The types of collagen present in the cartilage are 
I, II, IV, V, VI, IX, and XI; however, type II collagen represents 90–95% of the total 
amount. Collagen X, on the other hand, is only present in osteochondral ossification 
phases and, therefore, is associated with cartilage calcification [7].
Proteoglycans (PGs) represent 10–15% of the ECM and are the main noncol-
lagen proteins present in the cartilage. These macromolecules are responsible for the 
compression of cartilage. PGs are composed of one or more linear glycosaminogly-
can chains (GAGs) covalently linked [8].
At this point, we have reviewed the cellular and molecular components of joint 
tissue, but how are they connected to each other? The articular cartilage has a 
complex microarchitecture that varies from the articular surface to the subchondral 
bone, organized into the osteochondral unit (Figure 1).
The structure of the osteochondral unit is divided into four well-defined zones 
designated according to their morphological characteristics, that is, the content of 
proteoglycans or water and the density of chondrocytes in: superficial, the middle, the 
deep and the calcified zones (Figure 1). In particular, if the differences in the fibrous 
structure are understood, the terms “tangential,” “isotropic,” and “radial” have been 
used frequently. In consequence, the space between these zones allows, identifying 
three regions: the pericellular, the territorial, and the interterritorial region.
3. Histology and mechanical properties of the osteochondral unit
Each of these zones has a particular matrix composition, and cell morphology, 
which translates into different cellular, mechanical, and metabolic properties. It is 
difficult to separate the histological from the biomechanical when the cartilage is 
analyzed. The particular properties of loading and lubrication of articular cartilage 
is due, in part, to its composition, which includes a solid phase of collagen fibrils 
and proteoglycans entangled with a fluid phase [9]. The high tensile stiffness of the 
collagen considerably increases the compressive strength of the cartilage by also 
providing resistance to lateral expansion and allowing pressurization of the inter-
stitial water [10]. It is believed that fluid pressurization is an important reason why 
articular cartilage exhibits a very low coefficient of friction [11].
As heterogeneous material consisting of surface calcified superficial layers 
(10–20%), medium (40–60%), and deep (30%) and thin. Each layer has specific 
mechanical properties and is identified by different variations in the size and direc-
tion of the collagen fibers. The content of proteoglycans is lower in the surface area 
and increases with depth.
The superficial area is thin and protects the deeper layers of the shear stresses. It 
is mainly composed of collagen types II and IX hermetically packed and in parallel 
alignment with the articular surface. It contains flattened chondrocytes, which are 
influenced by synovial fluid. This area is responsible for the traction properties of 
cartilage (Figure 1).
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Below the surface area is the middle (transition) zone, which represents a bridge 
between the surface and deep zones. This zone contains a low density of spheri-
cal chondrocytes, proteoglycans, and fibrils of thicker collagen and is responsible 
for resistance to compression forces. The middle zone of the cartilage has looser 
collagen fibers, which gives it the greater Young compression modulus. It is these 
variations in tissue morphology that account for the tensile and shear strength 
properties of cartilage [12] (Figure 1).
The deep zone provides the greatest resistance to compression forces. It is 
formed of larger diameter collagen fibrils in a radial arrangement and a low amount 
of water. The chondrocytes are organized in a columnar orientation, parallel to the 
collagen fibers and perpendicular to the articular line (Figure 1).
Lastly, the calcified layer of hypertrophic chondrocytes joins the cartilage to the 
bone by anchoring the collagen fibrils from the deep zone of the subchondral bone 
(Figure 1) [13, 14].
Through the correlation between histology and mechanical properties, it is clear 
that the collagen network and the proteoglycan matrix within the articular cartilage 
play an important role in the control of the tensions around the chondrocytes, and 
in the maintenance of the good condition of the diarthrodial joints when regulating 
the biosynthesis of the solid matrix.
The effect of the collagen network and the fixed loading densities of the carti-
lage in the mechanical environment of the chondrocytes have been investigated in 
a depth-dependent manner. The current model emphasizes that the orientation of 
the collagen and the negative fixed charge densities dependent on the depth of the 
articular cartilage have a great effect on the modulation of the mechanical environ-
ment in the vicinity of the chondrocytes.
Apart from the structure, the composition of the cartilage is also important to 
determine the biomechanical properties of the tissue (e.g., traction, compression, 
and shearing). As mentioned above, collagen fibrils are the main contributors to the 
traction properties of articular cartilage. Since the different zones have different 
diameters of collagen and organization, the tensile properties vary significantly 
between the zones.
4. Clinical strategies for the osteochondral therapeutic approach
The injuries in the articular cartilage are able to stimulate a significant musculo-
skeletal morbidity not only in elderly patients but also in young people.
The restoration of damage from joint injuries to date represents a great challenge 
for medicine, since it cannot regenerate spontaneously; moreover, over time it can 
also lead to the establishment of osteoarthritis (OA).
The classification of articular cartilage injury is performed by instrumented 
palpation of the lesion and by direct observation by arthroscopy [15, 16]. The most 
complete classification system is established by the International Cartilage Repair 
Society (ICRS) [17]. The ICRS grading system evaluates the depth of the lesion and 
the degree to which the subchondral bone is involved to classify the injury as follows: 
grade 0 corresponds to a normal joint; grade 1 is presented by superficial lesions, soft 
cleft, and/or superficial fissures and cracks; grade 2 for abnormal lesions that extend 
to <50% of the depth of the cartilage; grade 3 due to serious abnormalities in which 
cartilage defects extend to >50% of the depth of the cartilage, as well as to the calci-
fied layer and up to, but not through, the subchondral bone; and grade 4 for severe 
abnormal where there is also development of blisters in the tissue [17].
Articular cartilage has a limited capacity for repair. Injured chondrocytes 
(either superficial or partial thickness lesions) from the early stages develop 
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defects in their metabolism; therefore, they are unable to maintain a normal 
concentration of PGs [18].
These modifications trigger the increase in tissue hydration and therefore the 
fibrillar disorganization of collagen [3, 19]. These changes favor an increase in the 
transmission of force toward the subchondral bone. By exceeding the capacity of 
the subchondral bone, the impact on the damaged cartilage is even deeper.
In response to this series of events, the chondrocytes proliferate and therefore 
the production of matrix molecules at the area of the lesion increases, however, the 
new matrix is not able to restore the native surface [3].
When the lesion reaches the subchondral bone (full-thickness lesions), the entry 
of pluripotent medullary elements is observed [20]. These migratory mesenchy-
mal stem cells produce type I collagen fibers to fill the full thickness defect with 
fibrocartilage. It should be noted that fibrocartilage is not capable of supplying the 
damping functions of articular cartilage [21].
Following this line of argumentation, the strategies designed for the treatment 
of articular cartilage lesions can classically be classified as discussed below.
Palliative as physiotherapy and systemic medications to relieve pain; reparative 
procedures such as debridement, washing of the knee and ankle joint, arthroscopic 
arthroplasty, microfracture, and bone marrow stimulation techniques; restorative 
such as high tibial osteotomy, unicompartmental knee arthroplasty and total knee 
arthroplasty; and transplantation such as osteochondral transplantation (osteo-
chondral graft), osteochondral autologous transplantation (OATS), and transplan-
tation of a autologous chondrocyte implantation (ACI) [22, 23].
4.1 Microfracture
Classified within the reparative procedures is the microfracture. Microfracture 
was introduced into the clinic after other techniques of bone marrow stimulation 
were used in the late 1980s and early 1990s to penetrate the subchondral bone. 
This technique improves the migration of MSCs from the bone marrow to the 
site of the cartilage defect; however, microfracture often results in the formation 
of fibrocartilage that is biochemically and biomechanically inferior to hyaline 
articular cartilage [24]. A case series study has shown that without the mechanical 
robustness of the hyaline tissue, the repair tissue is vulnerable to joint mechanical 
forces and typically deteriorates between 18 and 24 months after surgery. Such 
deterioration is particularly evident when treating large defects or those located in 
the patellofemoral joint [25].
Although the FDA and many physicians still consider microfracture to be the gold 
standard for cartilage repair, prospective comparative studies show that microfracture 
could delay cartilage degeneration only in the short term; more than 5 years after 
surgery, treatment failure can be expected regardless of the size of the lesion [26].
4.2 Osteochondral autologous transplantation (OATS)
Osteochondral autologous transplantation has been indicated majorly for 
small-to-medium size (diameter > 10 mm) focal articular cartilage or osteochondral 
defects of the weigh-bearing areas of the femoral condyles, patellofemoral joint and 
talus without an acceptable outcome after less invasive techniques [27].
In OATS, a single or multiple osteochondral grafts are harvested from either 
the less-weight-bearing parts of the femoral condyle or the costal-osteochondral 
junction. This surgical procedure has the advantage of transplanting viable hyaline 
cartilage and subchondral bone, which is then transplanted into the defect area to 
restore the integrity of the articular surface [28].
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The disadvantages are basically two: the availability of the grafts and the 
morbidity of the donor site. The major disadvantage of this procedure is the need 
to harvest one or multiple grafts from an asymptomatic knee or the rib area. 
Osteochondral harvesting in OATS often results in considerable donor-site mor-
bidity, showing rates of 17 and 6% for ankle and knee mosaicplasty procedures, 
respectively, without any significant correlation between the rate of donor-site 
morbidity and size of the defect, number, and size of the plugs [29]. Furthermore, 
there is limited evidence on the short- and long-term consequences from harvesting 
bone plugs of asymptomatic joints.
4.3 Implantation of autologous chondrocytes
The inconsistent results of microfracture opened the way to the development of 
autologous chondrocyte implantation (ACI). To perform this technique, a sample of 
cartilage of full thickness is collected from a region of the joint under heavy weight; 
this by means of a biopsy during a first arthroscopic operation, the biopsy would 
thus serve to provide a population of chondrocytes that would later be expanded 
in vitro, to generate around 12–48 million cells. During a second operation, the 
chondrocytes would implant in the defect of the debrided cartilage to finally be cov-
ered with a membrane. This technique has two main benefits: the use of a patient's 
own cells, which avoids possible complications related to immune events or viral 
infections when transplanting allogeneic cells or foreign materials, and unlike the 
autologous osteochondral implantation, the small biopsy minimizes complications 
in the donor zone of chondrocytes [30].
The positive clinical and functional results of the ACI have been confirmed by 
clinical trials [31, 32]. The series of long-term cases with 5 years of follow-up have 
shown that ACI is an effective and durable treatment for knee cartilage lesions 
greater than 4 cm2 [33, 34].
It should be noted, however, that the ACI has three main drawbacks:
• Two operations are needed; this makes the recovery time very long (6–12 
months) to guarantee the maturation of the neoformed tissue and thus achieve 
improved clinical scores from the beginning of the study.
• The most frequently reported adverse event after ACI, using a periosteal flap to 
seal the cells implanted in the cartilage defect, is flap hypertrophy [33]. Therefore, 
alternative approaches use artificial matrices such as porcine membranes consist-
ing of collagen mixtures types I and III or hyaluronic acid scaffolds [34–36]. These 
materials eventually increase the likelihood of an immune reaction, and their use 
is currently considered not approved in the United States.
• Preliminary studies have also shown that very often, autologous chondrocytes are 
"dedifferentiated" to fibrochondrocytes in culture [37]. Although other studies 
show that they can be redifferentiated and express chondrocytic markers after 
being reintroduced in an in vitro 3D culture system [38], large-scale cohort studies 
are needed to continue investigating the cost-effectiveness of the ACI in this regard.
4.4 Scaffolding-based techniques
Taking into consideration the systems that allow the grafted chondrocytes to 
be embedded in a three-dimensional system (3D), the osteotomy and autologous 
osteochondral graft transplantation has been suggested to restore normal joint 
congruity and minimize joint deterioration. Often, these techniques have not 
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resulted in long-term a clinical solution, which has prompted the development of 
approaches that involve regenerative medicine and tissue engineering to restore 
articular cartilage.
The lack of a support material or scaffold to guide the synthesis and organiza-
tion of the neoformed ECM could, in part, explain the variability of the results 
among the populations of patients treated with ACI techniques. Ex vivo studies have 
shown that successful regeneration of cartilage depends on both the proliferation 
rate of chondrocytes and the differentiation capacity of stem cells within a three-
dimensional scaffold designed by tissue engineering; this structure then acts not 
only as a vehicle or cellular support but also influences the properties especially the 
mechanical properties of the newly formed tissue [39].
5.  Tissue engineering based on multiphase designs for cartilage 
regeneration
Tissue engineering can be defined as the creation or induction of the formation 
of a specific tissue, in a specific location, through the manipulation and selection 
of cells, matrices, and biological stimuli. It is an interdisciplinary field that applies 
principles of engineering and life sciences toward the development of biological 
substitutes that restore, maintain, or improve tissue function [40].
Currently, tissue engineering combines the contribution of cells, undifferenti-
ated or not, which are placed into a scaffold where growth factors can be added to 
accelerate cell proliferation and differentiation so that after being transplanted to a 
damaged structure and reaching its regeneration.
5.1 Strategies for cartilage tissue engineering
In the cartilage tissue engineering, the constant development of new designs 
combining biomaterials, with different cellular sources and modifying the cell 
culture methodology within the scaffolding systems is driven by the need, still not 
satisfied, to have a gold standard for functional and long-term repair of chondral 
and osteochondral defects.
As a cellular source for the formation of cartilage, chondrocytes, or alternatively, 
mesenchymal stem cells can be used. In the case of mesenchymal stem cells, there are 
a series of known factors that induce their differentiation toward the chondral phe-
notype, among which are the use of a culture medium without serum, enriched with 
dexamethasone, ascorbate, TGFβ, and BMPs, being the method of three-dimensional 
cultivation at high density one of the most used for this purpose [41, 42].
For the implantation of cells in the cartilage defect, they should be embedded 
in the thickness of scaffolding. These cellularized graft needs to be maintained for 
some period of time in culture in order to allow the cells to secrete enough ECM 
to functionally replace the normal cartilage and facilitate its complete integra-
tion. A newly developed osteochondral construction with inferior mechanical 
properties can also contribute to mechanical imbalance near the defect region 
until its mechanical properties have matured [43]. Mayr et al. demonstrated that 
the cartilage component of the osteochondral graft had only half the rigidity 
of the surrounding cartilage 6 months after implantation [44]. The longer the 
osteochondral graft takes to mature into mechanical properties, the longer the 
surrounding cartilage will be exposed to an excessive load, which may contribute 
to degenerative processes. Therefore, it is necessary to select scaffolds that allow 
building structures related to the biological behavior of cells into an adequate 
environment. In any case, for the production of cartilage, it is important to achieve 
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the maximum production of extracellular matrix because the mechanical behavior 
of the implanted artificial tissue is favored, especially when using less resistant 
scaffolds than the normal articular cartilage.
The application of cells in scaffolds, as tissue engineering does, makes cartilage 
regeneration strategies complex but allows the process to be orchestrated efficiently. 
The critical point in these strategies is the expansion of the cells in culture in order 
to generate a suitable production of ECM in vitro and with a supportive impact on 
the mechanical properties in vivo [45].
Another challenge to overcome regarding this strategy is to achieve a competent 
integration of the graft after implantation. The integration of the implanted tissue 
with the organ requires remodeling, degradation, and at the end, formation of new 
tissue. The remodeling of the implanted tissue is essential for its functionality [45].
In the last decades, the strategies have been designed without considering 
the cartilage as a complex tissue with a functionally stratified three-dimensional 
structure. Today, efforts are focused on achieving a benchmark in the cartilage 
formation process with the development of a multiphasic implant, not only because 
it recapitulates the nature of native tissue, but also it takes advantage of the healing 
capability of bone to promote the implant integration with the surrounding tissue 
and then bone healing and cartilage formation. The architecture of the scaffold and 
the presence of migratory cells within or immediately around the graft in the bone 
phase of the osteochondral tissue then play a key role in the integration and there-
fore tissue repair.
5.2 Multiphasic scaffolding
During the last decade, there have been many new developments in various 
aspects of scaffolding manufacturing. Computer-aided designs and fabrication tech-
nologies are used to fabricate custom scaffolds for irregularly shaped defects [46, 47].
The materials used for scaffolds and matrices are increasingly intelligent 
and more versatile, and can be modified to incorporate bioactive peptides [48]. 
Although scaffold fabrication technologies are advancing at a rapid pace, no 
engineering strategy used to date can completely recapitulate the biochemical and 
physical characteristics of native osteochondral tissue. Although it is generally use-
ful to simplify the approach of in vivo repair from an engineering point of view, for 
a successful in vivo result, the biological complexities that take place within the joint 
must also be taken into account in the design.
The osteochondral tissue has a heterogeneous multilayer structure composed of 
uncalcified cartilage (superficial, middle, and deep zone), calcified cartilage and 
subchondral bone.
Essentially, a multiphasic scaffold should be biocompatible able to guide the 
structuring of new chondral and osseous tissue, taking into account the presence 
and biological functionality of the interface region between them (tidemark) to 
achieve the mechanical properties of articular cartilage. The widespread approach 
uses multicomponent systems, and the exquisite melding of natural and synthetic 
biomaterials where the assembly strategy is fundamental since it determines the 
topography and the structural arrangement in which the extracellular matrix is 
organized, a random or a well-ordered orientation of the fibers within the chondral 
phase in particular.
It can be postulated that the typical lack of orientation of the collagen fiber in 
the repaired cartilage also has a role in the prevention of a strong integration at the 
level of the cartilage. The surface area of the cartilage in the normal cartilage is hori-
zontally aligned, parallel to the direction of the joint. However, within the repaired 
cartilage, this provision is often lacking; therefore, the border adjacent to the native 
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cartilage tissue and modified by genetic engineering is susceptible to rupture. The 
vertical orientation of collagens near the subchondral bone has been attributed to 
the anchoring of cartilage tissue against large strains [49]. The lack of orientation of 
the collagen in a dynamic loading environment of the joint probably has a role in the 
in vivo failure of the implanted constructions and the decreased integration.
Additionally, it is well documented that the rigidity of the cartilage depends on 
the depth, and that the superficial layer of the cartilage deforms much more than 
the deeper layers [50]. In this respect, when the cartilaginous component of the 
osteochondral scaffolds lacks the deformation patterns that vary in depth, it is likely 
that the levels of compression deformation mismatched between the cartilage and the 
implant cause a higher shear stress in the interfacial region, causing a break. Tissue 
engineering cartilage grafts with variable depth compressive properties have also been 
proposed in the past [51], and can be incorporated into future osteochondral designs.
Multiphasic scaffolds can be designed considering two or three different phases 
(biphasic or three phase, respectively), each of them with an architecture and 
composition of particular biomaterials. Since the cartilage and the subchondral 
bone, part of the osteochondral unit, have different biological and mechanical 
requirements, the first approaches in the design of multiphase implants were based 
on the use of two different biomaterials in order to reach a tissue-specific scaffold 
design; moreover, the use of different combinations of biomaterials for each phase 
has been reported.
Polylactic-acid (PLA)-coated polyglycolic acid (PGA) scaffold molded by the 
computer-aided design and manufacturing (CAD/CAM) technology proved to 
be ideal scaffolds for cartilage regeneration, where the presence of PLA provides 
adequate rigidity for the chondral phase, which is attached to polycaprolactone/
hydroxyapatite (PCL/HA), an osteoconductive material, where HA generates 
a favorable topographical surface and biomimetic microenvironment in terms 
of bone tissue. The regenerated cartilage and subchondral bone showed a well-
structured transition zone between the two phases, which has resulted in a better 
integration with the host and with mechanical properties capable of supporting the 
solicitation of the chondral tissue [52].
The importance of generating in the scaffold a tissue-specific microenvironment 
that allows the undifferentiated migrant cells of the host to find a niche for the 
adequate differentiation toward the chondrocytic lineage is evident.
Yun-Jeong et al. have shown that not only the microenvironment generated by 
the composition of the biomaterials impact on a better imitation of the osteochon-
dral unit, but also the scaffolding structure has an important influence, being an 
aligned structure the most adequate in comparison with a randomly structured scaf-
fold [55]. A stratified design of aligned channels in a biphasic scaffold using collagen 
type I and biphasic calcium phosphate (BCP) to mimic the cartilage and bone tissue, 
respectively, was manufactured by using an exquisite unidirectional freeze-casting 
process. Collagen is flexible, and it has specific molecular domains able to induce and 
support cell bioactivity [53]. Likewise, BCP provides significant osteoconductivity, 
bioactivity, and mechanical features [54]. However, privileging on the composition, 
the generation of a biphasic scaffold with a longitudinal roughness of the inner 
channels that serves as a guide for the correct adhesion of the cells; it results in a 
topography that truly emulates the osteochondral unit and shows in vivo a superior 
regeneration of the osteochondral tissue compared to the random structure [55].
Therefore, not only the pore size and porosity should be taken into account for a 
correct design, but also the alignment of the channels within the scaffold influenc-
ing cell migration and the proper pattern fibers of the ECM.
Likewise, multiphase can be assembled on the basis of a single biomaterial. 
It is possible to modify the physical properties such as roughness, pore size, and 
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interconnectivity particularizing according to the phase, selecting a specific type 
of porogen and particle size, as well as through the use of different solvents and the 
polymerization process.
Biphasic scaffold with a cartilage phase consisting of a silk scaffold attached to 
a bone phase consisting of a strontium-hardystonite-gahnite (SHG)-silk scaffold 
has been designed by Jiao Li et al. [56]. The preparation implies a coating process 
of SHG ceramic scaffolds with a single silk layer using an aqueous silk fibroin 
solution then attached to the mixture of silk using methanol as an alternative 
solvent prior to silk scaffold formation in order to induce β-sheet formation in 
fibroin and the structure of the interface. The conformation of this design showed 
not only the ability to promote the differentiation of human mesenchymal stem 
cells toward the chondrogenic or osteogenic lineage, but also in addition, by 
having a well-stratified biphasic structure, the loading behavior validated the 
compression properties.
By the same token, a single biomaterial can be used and can generate distinct 
microenvironment using different molecules to biofunctionalize in a tissue-specific 
manner. Certainly, no biomaterial is intrinsically capable of satisfying all the 
requirements for the manufacture of complex and stratified tissues, so the biofunc-
tionalization of these is presented as an alternative procedure to adapt the proper-
ties of the biomaterials to the needs of the chondral or bone tissue.
A biphasic, but monolithic scaffolds based on alginate, a highly biocompatible 
natural biomaterial able to support the growth of diverse cell lineages is designed by 
Schütz et al. through its strategy; scaffolds are fabricated by a diffusion-controlled 
system that allows the directed ionotropic gelation [57]. The final structure leads to 
the formation of channel-like, parallel aligned pores. In order to generate a chondral 
environment, alginate is biofunctionalized with hyaluronic acid, while for the bone 
phase, hydroxyapatite is used.
This simple procedure generates two well-defined layers characterized by 
different microstructure and mechanical properties, which provide a suitable 
environment for cells to form the respective tissue. Although an interface between 
the chondral and bone areas of the implant is not structured, a stable connection 
between them is clearly demonstrated, which positively impacts the mechanical 
properties in the final design. According to the influence of biofunctionalization, it 
was demonstrated by gene expression analysis that the embedded stem cells differ-
entiated into the chondrogenic lineage when they were cultivated in chondrogenic 
medium; additionally, under the stimulation of the hyaluronic acid present in this 
phase, the chondrocyte phenotype remained stable.
Biofunctionalization, especially for monolithic scaffolds, is a useful alterna-
tive to provide chondro- and osteoinductive properties. Aragonite is a biomaterial 
from coral exoskeletons, similar to human bone including its 3D structure and 
pore interconnections as well as its crystalline form of calcium carbonate (CaCO3) 
[58]. That features confers improved osteoconductive ability, suitable for bone 
regeneration.
Interestingly, specific coral species differ in size and interconnectivity of 
coral pores, which expands the range of applications for different tissues. In 
order to induce chondrogenesis in a monolithic system of aragonite, the use 
of hyaluronic acid has been described by Korn et al. [59]. We have already 
discussed before, the relevance of channel generation aligned in parallel to 
guide the adhesion of the cells in the chondral phase and the subsequent struc-
turing of the ECM. In this design, in addition to the biofunctionalization with 
hyaluronic acid, the mechanical modification of drilled channels is also added. 
The combination of the two strategies showed in a model of joint damage in 
goat the best results compared to aragonite alone, and in the absence of parallel 
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channels; it means a cartilaginous repair tissue with hyaline cartilage as shown 
by the marked expression of proteoglycans, as well as of collagen type II and 
absence of collagen type I.
6.  Influence of vascularization on scaffold design for osteochondral 
regeneration
Vascularization is the bottleneck in tissue engineering. Creating constructs in 
the laboratory that lack of the proper vessels network will fail after implantation 
as the cells will not get enough oxygen and nutrients and will die. This fact is even 
more significant for osteochondral regeneration. Bone is a highly vascularized 
tissue while cartilage is avascular. When vascular networks invade cartilage surface 
from the subchondral zone, it might lead to an ossification of the cartilage from 
the deep and intermediate zone implying a joint damage and increasing pain. The 
design of the optimal scaffold to control angiogenesis, promoting vessel growth 
from preexisting ones, on the bone side and inhibiting it on the cartilage side is 
relevant for osteochondral regeneration.
One strategy to improve bone formation is to use growth factors (GFs) that can 
activate angiogenesis within the scaffold. There are several GFs involved in angio-
genesis, such as vascular endothelial growth factor (VEGF), platelet-derived GF 
(PDGF), bone morphogenic proteins (BMPs), fibroblasts growth factors (FGFs), 
and tumor growth factor beta (TGFβ) [60]. Uploading VEGF is widely used, as 
the VEGF activates endothelial precursor cell (EPC) migration and proliferation 
activating the angiogenic process, and subsequently promotes the recruitment and 
survival of bone forming cells improving bone regeneration. However, the presence 
of high levels of VEGF is one of the factors related to OA progression, inducing 
cartilage degeneration and pain [61].
Therefore, the scaffold design for osteochondral regeneration must fulfill different 
properties that are shared by the two tissues, such as cell adhesion and proliferation and 
a high production of ECM; but others must deal with angiogenic promotion for bone 
or angiogenic inhibition for cartilage. Furthermore, the already observed side effects 
of supraphysiological doses of bone-related GFs heterotopic bone growth, pseudoar-
throsis, local inflammation, and immune response [62] must be controlled by means of 
delivery vehicles that will ensure the bioactivity of these molecules and the remaining in 
the target location over the therapeutic timeframe. This can be done by covalent attach-
ment to the scaffold, noncovalent binding, or with the nanoparticle carriers.
Kempen et al. developed a system for the sequential release of VEGF with 
BMP-2. BMP-2-loaded PLGA microspheres in a poly(propylene fumarate) (PPF)-
scaffold combined with a VEGF-loaded gelatin hydrogel in a rat subcutaneous 
model demonstrated both improved vessel and bone formation when compared to 
scaffolds that did not contain VEGF [63].
García-Fernández et al. used antiangiogenic polymer based on 2-acrylamido-
2-methylpropane sulfonic acid (AMPS) and a methacrylic derivative of 5-amino-
2-naphthalenesulfonic acid (MANSA) [64]. The use of this synthetic polymer 
completely inhibited angiogenesis by the interaction of the sulfonic acid groups with 
the bFGF and VEGF modulating their activity in the processes of endothelial cell 
migration and proliferation. Thus, the fabrication of a biphasic scaffold by combining 
two different polymers that can control angiogenesis can be an efficient approach.
An innovative approach that has been tested recently is the use of 
microRNAs(miRNAs) to modulate cell activity for regenerative medicine 
applications. miRNA is a single-stranded RNA, with a length between 21 and 25 
nucleotides that can regulate gene expression, usually by destabilizing mRNAs or 
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by suppressing translation. The roles of these miRNAs on bone diseases (such as 
osteoporosis, osteoarthritis, and rheumatoid arthritis) have been recently high-
lighted. Five freely circulating miRNAs and bone tissue miRNAs are associated with 
osteoporotic fractures [65, 66]. miR-26a was reported to regulate angiogenesis by 
targeting BMP/SMAD1 signaling in endothelial cells [67].
The use of these molecules as miRNA regulators can be done by using synthetic 
molecules, which either mimic or repress the function of endogenous miRNAs. The 
mimicking molecules will enhance the suppression of the target protein synthesis 
by degrading the miRNA or inhibiting the protein translation. On the other hand, 
miRNAs inhibitors (antagomirs) preventing the activity inside the cells will lead to 
a rise of mRNA and protein expression. This approach can be used to upload scaf-
folds with either agonist or antagonist molecules to induce or avoid vascularization.
Many scaffolds have been designed to fulfill the function of miRNA delivery, 
mainly hydrogels, nanofibers, and porous or spongy scaffolds. Besides, the normal 
desired properties such as biocompatibility, easy fabrication, easy sterilization, 
proper mechanical properties, and adequate porosity for vessels growth, the mate-
rial must retain the miRNA complexes while facilitating their sufficient exposure to 
the infiltrating cells without affecting its mechanical properties [68].
7. Biomaterials for multiphasic scaffolding
Biomaterial scaffold properties are fundamental to guide and recreate the native 
environment. The biomaterials for osteochondral applications in first insight must 
be biocompatible and should be intrinsically osteoinductive, osteoconductive, 
chondroinductive, or chondroconductive, and not less insignificant, and must pos-
sess a degradation rate that allows the formation of new tissue.
As previously stated, an ideal scaffold for the treatment from a multiphase point 
of view must have a chondrogenic matrix that is flexible, resistant and with pores 
small enough to mimic the hyaline cartilaginous matrix and an osteogenic matrix 
that should be mechanically competent similar to cancellous bone and bioactive, 
which has larger pores that mimic the microenvironment of the subchondral bone.
Achieving an articular cartilage design capable of mimicking its anisotropic 
mechanical behavior, still represents one of the greatest challenges in the cartilage 
tissues engineering [69]. In addition, the ideal biomaterial for cartilage should allow 
the cartilage composition to be recreated in terms of the liquid and solid phases of the 
connective tissue, reproduce its zonal organization, and facilitate the integration of the 
neoformed tissue with the adjacent native tissue.
Functionally, we can classify biomaterials into: protein-based polymers, such 
as fibrin, gelatin, collagen, and silk fibroin [70–74]. Biopolymers based on carbo-
hydrates such as alginate, chitosan, agarose and polyethylene glycol [75–78], and 
synthetic polymers such as polylactic acid, polyglycolic acid, polycaprolactone and 
polylactic-coglycolicacid (PLGA) are the most common [79–81].
7.1 Carbohydrate-based polymers
These kinds of biomaterials are comprised of cross-linked polymers that swal-
low a great amount of water, which empathizes with the features of cartilage ECM, 
thus favoring the maintenance of spherical morphology within the scaffold [76]. 
Furthermore, synthetic materials and growth factors can be added in order to 
enhance chondrogenesis.
A material with adequate characteristics for cartilage engineering is chitosan, 
a polycationic polysaccharide that can be degraded enzymatically by the lysozyme 
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present in the MEC of human cartilage. Chitosan has a chemical similarity with 
GAGs, which gives it the ability to interact with them [82]; through various in 
vitro studies, it has been demonstrated that scaffolds based on chitosan especially 
in combination with other biomaterials such as collagen II [108], hyaluronic acid 
[83], or fibroin [84] promote chondrogenic activity and support the production of 
aggrecan and type II collagen, thus improving cartilage repair [108].
7.2 Protein-based polymers
Among the materials of a protein nature is gelatin, which is formed from 
denatured collagen and can bind to growth factors, proteins, and peptides and is 
also capable of promoting efficient cell adhesion. On the other hand, there is the 
collagen that constitutes the main structural component of the ECM, and its use as a 
scaffolding material allows the cells to retain their phenotypes [85].
Collagen is a naturally occurring protein found in various fibrous tissues such 
as bone and cartilage. Collagen-based scaffolds have been used for cartilage tissue 
engineering applications as biomaterials due to its biocompatibility and biodegrad-
ability. Type I collagen gels seeded with bone marrow-derived MSCs have shown the 
formation of cartilage and subchondral bone after implantation in a full-thickness 
osteochondral defects macaque model. After 24 weeks, the defect had been covered 
with cartilage-rich reparative tissue, suitable integration with the surrounding 
cartilage tissue, and restoration of trabecular subchondral bone [86].
As part of this group of biomaterials is the silkworm fibroin, which is a natural 
biopolymer, with properties such as biocompatibility and biodegradability that allow 
it to be currently used for the development of a wide variety of biomedical devices 
and new regeneration technologies [87]. Fibroin is the main constituent (72–81%) of 
silkworm cocoons Bombyx mori [88], is a hydrophobic glycoprotein containing a large 
amount of hydrogen bonds, its composition and molecular orientation allows the for-
mation of a semicrystalline structure formed by a highly ordered phase of antiparallel 
β-sheets that give it strength and tenacity, separated by less ordered β-sheet spacers 
that in turn contribute to the flexibility and elasticity of the fiber [89].
Because of these unique intrinsic properties and their versatility, silk alone is used 
as a biomaterial for biotechnological processes and as well as in tissue engineering [56, 
90, 109]; however, it can also be combined with other polymers; the combination of 
fibroin/hyaluronic acid is reported, which favors the cultivation of mesenchymal stem 
cells [91]. In this context, silk fibroin has interesting applications in the engineering 
of hard and soft tissues and has diverse characteristics among which is included the 
ability to support the proliferation and differentiation of various cell types, making it an 
attractive therapeutic candidate in cartilage regenerative medicine (Table 1) [56, 109].
Silk fibroin has been used in several medical applications, and it can be used 
as fiber [92], electrospun fibers [93], films [94], or hydrogels [95]. The versatility 
of fibroin as a biomaterial makes it suitable for any type of application in tissue 
engineering, and applications that demonstrate greater maturity and close to its 
final application are in the field of regeneration of bone, cartilage, and ligaments.
In this regard, a very interesting application is the reconstruction of the cruciate 
ligament of the knee through the elaboration of a cord of silk fibers that later are 
sown with mesenchymal cells of the bone marrow that differentiate to ligament tis-
sue, offering a mechanical resistance much superior to that of other organic materi-
als and a great biocompatibility. This application is already in commercial phase 
in the United States, by a company specialized in the development of biomaterials 
based on silk fibroin (Serica) [96].
Regarding the regeneration of cartilage, fibroin has been used for the manufacture of 
biphasic implants in combination with bioactive ceramics or 70S bioactive glass, which 
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Multiphasic design In vitro evaluation Preclinical evaluation Clinical evidence References
Bilayered scaffold using microfibrillar articular 
cartilage extracellular matrix (ACECM) and 
cellularized with rabbit chondrocytes [chondral phase], 
attached to ACECM and nanophase hydroxyapatite 
(HAp) [bone phase]
A gradual interfacial region was formed; for chondral 
phase, intensely stained with safranin O and toluidine 
blue, indicating an ECM rich in sulfated proteoglycans, 
while bone phase a positive alizarin red staining of the 
lower layers indicated the rich Ca content
Not performed Not performed [106]
Juvenile ovine articular chondrocytes (joACs) 
embedded in agarose [chondral phase], attached to 
hydroxyapatite (HAp) ceramics [bone phase]
Suitable compressive strength due to HAp. 
Chondrocytes were densely packed in a GAGs and 
collagen-rich ECM, showing a zonal organization 
reminiscent of native cartilage
Not performed Not performed [107]
Chondrocyte cultivated on a biphasic, type II 
collagen–chitosan, attached to poly(lactic-co-
glycolic acid) [PLGA] bone scaffold
Efficient integration between chondral and bone 
phases with suitable pore size differences. In 
vitro chondrogenic differentiation confirmed by 
the expression of collagen type II, Sox-9 and a 
remarkable upregulation of aggrecan
Not performed Not performed [108]
Biphasic scaffold with a cartilage phase consisting 
of a silk scaffold attached to a bone phase consisting 
of an SHG-silk scaffold (strontium- hardystonite-
gahnite), and cellularized with hMSCs from bone 
marrow
A well-integrated interface with a stratified 
compressive properties according to 
osteochondral tissue. The structuring and 
maturation of the ECM congruent with the 
distribution and structure of the hyaline cartilage
Not performed Not performed [56]
Biphasic scaffold with a cartilage phase consisting of 
a silk scaffold well integrated to a silk-nanocalcium 
phosphate as a bone phase, and cellularized with rabbit 
bone marrow mesenchymal stromal cells
No data are presented In a rabbit knee critical size 
osteochondral model. By histological and 
immunohistochemical analysis, cartilage 
regeneration and abundant presence 
of glycosaminoglycan and collagen II 
were observed. The formation of de novo 
subchondral bone and blood vessels were 
also observed
Not performed [109]
A biphasic hydrogel composed by methacrylated 
chondroitin sulfate (CSMA) as chondral phase, and 
acryloyl chloride-poly(ε- caprolactone)-poly(ethylene 
glycol)- poly(ε-caprolactone)-acryloyl chloride (PECDA) 
as bone phase, with an interface of alginate; and 
cellularized with chondrocyte and osteoblast, respectively
Strong interfacial bonding and improved mechanical 
properties; highly interconnected porous structure 
suitable for cellular adhesion and growth in tissue-
specific way
The scaffold induced a very weak 
inflammatory response and in a rabbit, 
osteochondral defect model provided 
a temporary structure and an adequate 
microenvironment for the ingrowth of 
osteochondral newly formed tissue
Not performed [110]
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Multiphasic design In vitro evaluation Preclinical evaluation Clinical evidence References
Biphasic acellular scaffold with a cartilage phase 
consisting of hyaluronic acid attached to a bone 
phase consisting of aragonite
Scaffold has an interconnecting porosity, with 
an average of 100-μm pore size, able to support 
human stem cell adhesion
Using a goat model of a critical 
osteochondral defect, the formation of 
hyaline cartilage and subchondral bone 
regeneration in the area of the lesion is 
demonstrated [111]
The scaffold was used on an 
Outerbridge grade IV promoting 
the mesenchymal stem-cell 
migration, and after 24 months, 
the articular surface appeared 
restored by MRI (Agili-C™ ) 
[112]
[111, 112]
Acellular scaffold made from polylactide-
coglycolide copolymer and a bone phase containing 
calcium sulfate
A porous and resorbable scaffold with an 
osteoinductive environment due to the added 
calcium sulfate. The polyglycolic acid fibers, 
which are arranged in an orderly manner, give the 
structure a mechanical reinforcement [113]
Using a goat model of a critical 
osteochondral defect, a good filling 
of osteochondral defects, suitable 
integration with the native cartilage, 
and a high percentage of hyaline-like 
cartilage were demonstrated [114]
Reports in the literature about 
TruFit™ are controversial. 
It has been reported a poor 
integration of the implant with 
the surrounding tissue and poor 
bone regeneration [119, 120]. 
By contrast, it it has been used 
on an Outerbridge grade III and 
IV. Magnetic resonance imaging 
(MRI) shows an adequate 
integration of bone scaffolds in 
studied cases for more than 5 
years and a sufficient restoration 
of the articular cartilage 
(Trufit™ ) [115]
[113–115, 
119, 120]
Acellular, tri-phasic biomimetic scaffold with a 
cartilage phase consisting of equine type I collagen, 
a tidemark layer consisting of type I collagen and 
magnesiumhydroxyapatite (Mg-HA), attached to 
the bone phase consisting of a mineralized blend of 
type I collagen and Mg-HA
No data are presented By sheep and horse model, the 
secretion of type II collagen in the 
cartilage region, and a uniform 
presence of type I collagen in the 
subchondral layer were evidenced. 
Also, the regeneration with good 
quality and well-integrated tissue was 
demonstrated [117, 118]
The scaffold has been used on an 
Outerbridge grade III and IV. MRI 
was performed and evaluated by 
magnetic resonance observation 
of cartilage repair tissue 
(MOCART) score. All the scores 
improved significantly from the 
baseline (Maioregen™) [116]
[116–118]
Table 1. 
Multiphasic designs for osteochondral repair.
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has allowed the obtaining of scaffolds with stratified properties capable of satisfying the 
complex and diverse regenerative requirements of the osteochondral tissue [97].
7.3 Synthetic polymer-based biomaterials
Several biodegradable and biocompatible polymers of synthetic origin have 
been developed for biomedical applications. The aliphatic polyesters, that is, poly 
(α-hydroxy esters), represent polymers that have great potential for their applica-
tion in tissue regeneration. In this group are listed: poly (lactic acid) (PLA), poly 
(glycolic acid) (PGA), and poly (ε-caprolactone) (PCL) [12, 13]. There are three 
enantiomers of PLA, L-lactide, D-lactide, and mesolactide [98]. Of these, the most 
used are poly (L-lactide) (PLLA) and poly (D-lactide) (PDLA) [99]. Both PLLA 
and PDLA have a tensile strength and elongation at break (1–8%) [100, 101], its 
nature of slow crystallization predisposes that these materials are typically hard and 
brittle. In vivo studies have shown that highly crystalline PLLA degrades completely 
in 5 years, while mostly amorphous PDLLA loses strength in less than 2 months and 
is degraded in 1 year [102].
The material properties, degradation rates, and tissue compatibility of PLA can be 
modified by copolymerization with other monomers, resulting in copolymers such as 
poly (lactic acid-co-caprolactone) (PLGA), poly (lactic acid-co-caprolactone) (PLCL), 
poly (lactic acid-co-ethylene glycol) (PLEG), and poly (lactic acid-co-glutamic acid) 
(PLGM); this makes them biomaterials with highly adaptable properties for broad 
biomedical applications (Table 1) [108, 110, 113–115].
The most common synthetic material used for cartilage tissue engineering has 
been nonwoven PGA and PLA mesh. PGA has demonstrated good chondrogenesis 
both in vitro and in vivo [103]. A combination of a cell-free poly (L-lactic-coglycolic 
acid) scaffold and in situ bone marrow stem cells has been used for focal full-
thickness cartilage defects in a rabbit model, demonstrating suitable integration of 
the implant and hyaline-like cartilage regeneration in 24 weeks [104].
These polymers have been approved by FDA: a PGA, PLA, and also polydioxa-
none-based copolymer; BioSeed1, BioTissue Technologies, Freiburg, Germany has 
been used for hyaline cartilage regeneration in human trials. This scaffold is cel-
lularized with autologous articular chondrocytes showing improved clinical scores 
in human trials [105].
8. Current clinical applications of multiphase designs
The restoration of osteochondral tissue damage should be focused on the 
physiological features and the structure of the tissues that make it up (cartilage and 
bone), considering the different microenvironments that coexist in the native tis-
sue. Through tissue engineering, multiphase designs have been developed, such as 
those discussed throughout this chapter that aspire to achieve this goal. Currently, 
the vast majority of them have been characterized in vitro; some already have an 
in vivo analysis in medium and large species, which brings them closer to clinical 
application. Although there are few multiphase designs that are currently available 
for a clinical application, they open an important direction for the rigorous evalua-
tion of the designs found on this path.
The Agili-C™ CartiHeal is a biphasic scaffold, which consists in of a cartilage 
phase made of hyaluronic acid and a bone layer comprised by crystalline arago-
nite (calcium carbonate based). After in vivo trial (goat model), this acellular 
scaffolds evidenced the potential to recruit cells from the host tissues, and 
enhanced hyaline cartilage formation and subchondral bone regeneration with 
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a continuous maturation process without deterioration of the repair tissue after 
12 months implanted in critical osteochondral defects [111]. For clinical trials, 
only one clinical case has been reported in a 47-year-old man with an injury 
Outerbridge grade IV. The lesion was treated successfully and resumed normal 
activity after 18 months. In a follow-up at 24 months, restoration of the articular 
surface was demonstrated by MRI [112]. Although the results were encouraging, 
the occupation of the patient (athlete) could have a positive influence on the 
observed result, this makes it necessary to develop clinical trials in a larger num-
ber of patients under controlled conditions in order to extrapolate the benefits to 
a wider segment of the population.
The TruFit™ CB is an acellular scaffold made from polylactide-coglycolide 
copolymer and a bone phase containing calcium sulfate. The scaffold was used at 
first by direct implantation for the treatment of focal articular surface defects, but 
it showed some controversial results [113]. Several clinical studies have described 
a slow chondral restoration in the area of the lesion, due to poor bone repair [119], 
together with the poor integration of the implant with the surrounding tissue [120]. 
The long-term follow-up (up to 2 years) have also been controversial; however, 
the constant was delayed formation of the subchondral lamina [121]. Due to these 
clinical data, a thorough review of TruFit™ CB�s design is necessary before arriving 
at an effective clinical application.
Maioregen™ is a triphasic biomimetic scaffold where the cartilage phase con-
sists of equine type I collagen, an intermediate (tidemark like) layer consisting of 
type I collagen and magnesium-hydroxyapatite (Mg-HA), attached to the bone 
phase consisting of a mineralized blend of type I collagen and Mg-HA [116]. By 
preclinical tests on sheep and horses, it was possible to demonstrate the safety of 
the implant, but also that allowed the regeneration of the type II collagen-rich tissue 
after 6 months; this is a cell-free design [117, 118]. Throughout several clinical trials 
developed in such diverse populations ranging from 28 to 60 years and with a lesion 
size ranging from 1.5 to 6.0 cm2, a good filling of the lesion and integration of the 
graft has been observed as a constant result. The evolution of the regeneration 
process has demonstrated the formation of subchondral bone and maturation of the 
chondral tissue in a period of 6 months. The evaluation by a high-resolution mag-
netic resonance imaging (MRI) shows the complete repair of the tissue in a period 
of 2 years in 66.7% of the cases treated, even in cases where the lesion involves the 
subchondral bone [116].
9. Conclusions
A cartilage repair treatment using tissue engineering comprises the implanta-
tion of bioabsorbable scaffolds that at first fill a chondral or osteochondral defect, 
then the production of cartilage repair tissue depends on the de novo synthesis of 
cartilage matrix elements. Such scaffolds support the local migration of cells (chon-
drogenic or osteogenic) that basically synthesize new extracellular matrix. The aim 
of all cartilage replacement strategies should focus on reconstruction of hyaline 
cartilage with its hierarchical organization; however, most of the current strategies 
based on monophasic designs lead to the production of fibrocartilage, which has 
inferior biological and mechanical characteristics compared to hyaline cartilage.
The design of multiphasic scaffolds aims at congruence with that of hierarchical 
nature, and from the studies that have been carried out over the past few years, it is 
clear that as a consequence, it substantially improves the integration of the implant 
with the surrounding osteochondral tissue, and positively influences the functional 
regeneration of both chondral and bone tissues. A vast array of multiphasic designs 
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has been evaluated in vitro; however, only three are currently available in the clinic; 
the question that arises is: how to optimize the efforts to achieve a conclusive clini-
cal application?
The use of scaffolding in order to recapitulate as much as possible the hierar-
chical structure seems to be not enough. The decision to cellularize or maintain 
a cell-free scaffold is crucial, and the answer will depend on the 3D system in a 
particular way; therefore, cellularization in each of the chondral and bone phases 
must be taken into account for the final design. On the other hand, the inclusion of 
an in vitro maturing time of the cellularized implant is desirable; thus, at the time 
of implantation, the graft has enough mechanical characteristics to support the 
mechanical request in the joint.
The needed to mimic the ECM on a molecular level is another main goal that 
demands to be taken into account, so the bioactivation of the biomaterials with 
elements such as synthetic materials as the ceramics (tricalcium phosphate, 
hydroxyapatite, and bioactive glass), or even the same decellularized tissue matrix, 
turns out to be a valuable tool for cartilage design, since these materials enhance the 
growth of a bone-like layer to support the overlying cartilage to the existing osteo-
chondral defect.
Experimental studies are ongoing to evaluate innovative multiphase designs 
regarding the interaction with cells and the environment in an in vivo frame-
work. In vivo trials using small animal models provide innovative concepts in 
osteochondral tissue engineering; nonetheless, to reach the development of 
clinical trials in humans, it is important to follow successful experiments using 
animal models that have loads and joint dimensions similar to humans. Animals 
such as sheep, pigs, and horses have surgically created defect sizes ranging from 
0.29 to 0.79 cm2 and have average human-like defects depths of about 0.68–1 cm. 
The body weights of these animals are also comparable or much heavier than 
humans, which makes them more appropriate models to predict the results in 
clinical trials.
Although the challenge to incorporate the use of multiphase designs to the clinic 
is still great, from the results observed in the wide range of studies, it is possible 
to conclude that tissue engineering approaches based on multiphasic scaffolds 
represent a promising therapeutic treatment for the regeneration of osteochondral 
defects. Moreover, based on the clinical results, it seems that a three-phase approach 
offers the most promising results with patients.
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